Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Malcolm W. Macnab"'
Autor:
Michael H. Court, Jerold S. Harmatz, Noah Berkowitz, Diane E. Peters, Malcolm W. MacNab, Lauren E. Oleson, Miguel A. Zinny, David J. Greenblatt
Publikováno v:
British journal of clinical pharmacology. 68(6)
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • The viral protease inhibitor ritonavir is known to inhibit clearance of intravenous midazolam. • ALT-2074, a catalytic mimic of glutathione oxidase, inhibits human cytochrome P450 3A (CYP3A) isoforms in
Autor:
Susan Mallows, Malcolm W. Macnab
Publikováno v:
Clinical Cardiology. 14:33-37
Data from clinical trials with benazepril suggest that the safety profile of benazepril is similar to that of other angiotensin-converting enzyme (ACE) inhibitors. Treatment-related side effects occurred in 20% of benazepril-treated patients and in 1
Publikováno v:
European Journal of Pharmacology. 103:321-326
Tamoxifen is known to have both agonist and antagonist properties. Classical receptor theory predicts that given the relative concentrations of a partial agonist and full agonist acting on the same receptor, the partial agonist may reduce the effect
Publikováno v:
Psychopharmacology. 85:431-435
Critical flicker-fusion frequency (CFF) has often been applied to psychotropic drug evaluation as a measure of cortical arousal. There are several variables that must be considered for proper conclusions to be obtained from CFF experimental data. Psy
Publikováno v:
American journal of hematology. 18(4)
Idiopathic thrombocytopenic purpura (ITP) may develop during pregnancy or affect later pregnancies, causing serious risks of bleeding to the mother and fetus. High-dose intravenous immunoglobulin (IGIV) has caused an immediate and predictable rise in
Autor:
Malcolm W. Macnab, Ted D. Friehling, Gerald J. Kelliher, Lewis Wetstein, Peter R. Kowey, Kathleen M. O'Connor
Publikováno v:
American heart journal. 111(4)
Release of thromboxane (TXA 2 ) during acute myocardial infarction may be an important contributing factor in the genesis of ventricular fibrillation (VF). We assessed the effect of selective TXA 2 inhibition on vulnerability to VF after total occlus